LP-128
/ Lupeng Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
April 03, 2025
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=104 | Active, not recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Trial completion date: Dec 2024 ➔ Dec 2026 | Trial primary completion date: Dec 2024 ➔ Sep 2026
Trial completion date • Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
February 28, 2024
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=104 | Active, not recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2023 ➔ Dec 2024 | Trial primary completion date: Dec 2023 ➔ Dec 2024
Enrollment closed • Trial completion date • Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
September 11, 2023
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=104 | Recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Trial primary completion date: Jun 2023 ➔ Dec 2023
Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
February 24, 2023
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=104 | Recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Trial completion date: Mar 2023 ➔ Dec 2023 | Trial primary completion date: Dec 2022 ➔ Jun 2023
Trial completion date • Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
October 13, 2022
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=90 | Recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Trial completion date: Dec 2022 ➔ Mar 2023
Trial completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
August 03, 2022
A Study of LP-128 Capsules in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=88 | Recruiting | Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. | Trial completion date: Jul 2022 ➔ Dec 2022 | Trial primary completion date: Jun 2022 ➔ Oct 2022
Trial completion date • Trial primary completion date • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 6
Of
6
Go to page
1